On the contrary, the TIS data obtained for SDH-deficient GISTs, paired to a lower EIIS expression and to the tumor immune microenvironment depletion, suggested that this GIST subgroup should be considered a noninflamed tumor for which immunotherapeutic approaches are far from being taken into consideration. The gene discussed is SDHB; the disease is gastrointestinal stromal tumor.